Discontinuation report APO-ALENDRONATE

Last updated on 2019-12-20 History
Report ID 60163
Drug Identification Number 02248728
Brand name APO-ALENDRONATE
Common or Proper name ALENDRONATE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-05-31
Actual discontinuation date
Remaining supply date 2020-05-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-12-20 French Compare
v7 2019-12-20 English Compare
v6 2019-12-20 French Compare
v5 2019-12-20 English Compare
v4 2018-12-28 French Compare
v3 2018-12-28 English Compare
v2 2018-09-07 French Compare
v1 2018-09-07 English Compare

Showing 1 to 8 of 8